Table 4 Mediation analysis between Flavodiet Score and type 2 diabetes.
Flavodiet Score (1-point increments) | ||||||||
|---|---|---|---|---|---|---|---|---|
Participants, No. | Total effect (HR; 95% CI)a | P value | Direct effect (HR; 95% CI)a | P value | Natural indirect effect (HR; 95% CI)a | P value | Proportion mediated Log(NIE) / (Log(NIE)+log(NDE)) | |
Potential mediators (HR; 95% CI)b | ||||||||
Obesity and sugar metabolism | ||||||||
BMI | 80,877 | 0.957 [0.930–0.985] | 0.003 | 0.960 [0.932–0.987] | 0.005 | 0.998 [0.996–0.999] | 0.001 | 5% |
IGF-1 | 76,111 | 0.949 [0.921–0.977] | <0.001 | 0.950 [0.923–0.978] | 0.001 | 0.999 [0.998–1.000] | 0.001 | 2% |
Inflammatory biomarkers | ||||||||
C-reactive protein | 76,377 | 0.948 [0.921–0.977] | <0.001 | 0.949 [0.921–0.978] | 0.001 | 0.999 [0.998–0.999] | <0.001 | 2% |
Kidney function | ||||||||
Cystatin C | 76,528 | 0.948 [0.921–0.977] | <0.001 | 0.950 [0.923–0.979] | 0.001 | 0.998 [0.997–0.999] | <0.001 | 4% |
Urate | 76,453 | 0.948 [0.921–0.976] | <0.001 | 0.949 [0.922–0.977] | 0.001 | 0.999 [0.998–1.000] | 0.004 | 2% |
Creatinine | 76,480 | 0.948 [0.921–0.977] | <0.001 | 0.948 [0.921–0.976] | <0.001 | 1.000 [0.999–1.000] | 0.579 | NA |
Liver function | ||||||||
Gamma glutamyl transferase | 76,484 | 0.951 [0.923–0.979] | 0.001 | 0.951 [0.924–0.980] | 0.001 | 0.999 [0.999–1.000] | 0.001 | 2% |
Alanine aminotransferase | 76,506 | 0.951 [0.923–0.979] | 0.001 | 0.953 [0.925–0.981] | 0.001 | 0.998 [0.997–0.999] | <0.001 | 4% |
Aspartate aminotransferase | 76,262 | 0.950 [0.922–0.978] | 0.001 | 0.950 [0.922–0.978] | 0.001 | 1.000 [0.999–1.000] | 0.937 | NA |
Lipid metabolism | ||||||||
LDL-direct Cholesterol | 76,394 | 0.949 [0.921–0.977] | <0.001 | 0.949 [0.922–0.977] | 0.001 | 1.000 [0.999–1.000] | 0.089 | NA |
Lipoprotein(a) | 61,625 | 0.934 [0.903–0.965] | <0.001 | 0.934 [0.903–0.966] | <0.001 | 1.000 [0.999–1.000] | 0.803 | NA |